The objective of this study was to examine the quality of life in patients with Parkinson's
disease (PD) in a community‐based sample (n= 228 patients) using a Medical Outcomes …

Regional neuronal loss in the substantia nigra was studied in relation to extrapyramidal
symptoms and dementia in 12 patients with idiopathic Parkinson's disease (PD) and in 18 …

Survival and causes of death of 218 patients with Alzheimer's disease (AD) and of 115
patients with multi‐infarct dementia (MID) were examined. The patients were originally found …

Objective: To study the effect and safety of entacapone as an adjunct to levodopa treatment
in patients with PD with wearing-off motor fluctuations. Background: Entacapone is a …

This multicentre randomised double-blind 3-to 5-year trial was designed to assess whether
initial therapy with cabergoline alone or in combination with levodopa prevents or delays the …

Previous studies based on single sections have suggested a significant correlation between
pigmented neuronal loss in the substantia nigra (SN) and clinical features in Parkinson's …

Oxygen-derived toxicity has been suggested as being involved in the pathogenesis of
Parkinson's disease. Superoxide dismutase, catalase, glutathione peroxidase, and …

Long‐term survival was examined for 218 patients with Alzheimer's disease (AD) and 115
patients with multi‐infarct dementia (MID). The 14‐year survival rate for AD was 2.4% versus …

Parkinson's disease is a progressive disorder and no permanent cure has ever been
documented. The clinical onset, which usually occurs at an age of 55–65 years, is probably …

A two‐phase epidemiological study of essential tremor was carried out by investigating a
rural population aged over 40 years in 2 municipalities in southwestern Finland. In the first …